TBL1XR1 and acute promyelocytic leukemia: However, in our previous case report, we observed one APL patient with TBLR1-RARα fusion gene achieved CR after receiving ATO combined with chemotherapy, indicating that APL with TBLR1-RARα fusion gene may be sensitive to ATO treatment 2.